583 related articles for article (PubMed ID: 23588144)
21. [Dermatologic Manifestations in Inflammatory Bowel Disease].
Suh HY; Lee WJ; Na SY
Korean J Gastroenterol; 2019 May; 73(5):285-293. PubMed ID: 31132835
[TBL] [Abstract][Full Text] [Related]
22. Sweet's syndrome complicating ulcerative colitis: a rare association.
Lopes Caçola R; Soares M; Cardoso C; Furtado A
BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26791120
[TBL] [Abstract][Full Text] [Related]
23. Pyoderma gangrenosum and Sweet syndrome: the prototypic neutrophilic dermatoses.
Wallach D; Vignon-Pennamen MD
Br J Dermatol; 2018 Mar; 178(3):595-602. PubMed ID: 26202386
[TBL] [Abstract][Full Text] [Related]
24. A continuous spectrum of neutrophilic dermatoses in Crohn's disease.
Mendoza JL; García-Paredes J; Peña AS; Cruz-Santamaría DM; Iglesias C; Díaz Rubio M
Rev Esp Enferm Dig; 2003 Mar; 95(3):233-6, 229-32. PubMed ID: 12760712
[TBL] [Abstract][Full Text] [Related]
25. What do autoinflammatory syndromes teach about common cutaneous diseases such as pyoderma gangrenosum? A commentary.
Butler D; Shinkai K
Dermatol Clin; 2013 Jul; 31(3):427-35. PubMed ID: 23827245
[TBL] [Abstract][Full Text] [Related]
26. [Cutaneous and mucosal manifestations of inflammatory bowel diseases].
Károlyi Z; Erós N; Ujszászy L; Nagy G
Orv Hetil; 2000 Jun; 141(25):1391-5. PubMed ID: 10934882
[TBL] [Abstract][Full Text] [Related]
27. [Cutaneous aseptic abscesses, manifestations of neutrophilic diseases].
Carvalho P; Cordel N; Courville P; Leloet X; Heron F; Lauret P; Joly P
Ann Dermatol Venereol; 2001 May; 128(5):641-3. PubMed ID: 11427800
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of anti-interleukin-1 receptor antagonist anakinra (Kineret®) in a case of refractory Sweet's syndrome.
Kluger N; Gil-Bistes D; Guillot B; Bessis D
Dermatology; 2011; 222(2):123-7. PubMed ID: 21464561
[TBL] [Abstract][Full Text] [Related]
29. [Cutaneous manifestations in inflammatory bowel disease].
Chavez-Álvarez S; Gómez-Flores M; Ocampo-Candiani J
Gac Med Mex; 2016; 152(5):622-630. PubMed ID: 27792697
[TBL] [Abstract][Full Text] [Related]
30. Familial Sweet's syndrome in 2 brothers, both seen in the first 2 weeks of life.
Parsapour K; Reep MD; Gohar K; Shah V; Church A; Shwayder TA
J Am Acad Dermatol; 2003 Jul; 49(1):132-8. PubMed ID: 12833027
[TBL] [Abstract][Full Text] [Related]
31. Characterizing the presence of neutrophil extracellular traps in neutrophilic dermatoses.
Eid E; Safi R; El Hasbani G; Aftimos V; Abbas O; Kibbi AG; Nassar D
Exp Dermatol; 2021 Jul; 30(7):988-994. PubMed ID: 33969538
[TBL] [Abstract][Full Text] [Related]
32. Role of inflammatory cells, cytokines and matrix metalloproteinases in neutrophil-mediated skin diseases.
Marzano AV; Cugno M; Trevisan V; Fanoni D; Venegoni L; Berti E; Crosti C
Clin Exp Immunol; 2010 Oct; 162(1):100-7. PubMed ID: 20636397
[TBL] [Abstract][Full Text] [Related]
33. Neutrophilic dermatoses: pyoderma gangrenosum and Sweet's syndrome.
Lear JT; Atherton MT; Byrne JP
Postgrad Med J; 1997 Feb; 73(856):65-8. PubMed ID: 9122099
[TBL] [Abstract][Full Text] [Related]
34. Neutrophilic dermatosis resembling pyoderma gangrenosum in a dog with polyarthritis.
Bardagí M; Lloret A; Fondati A; Ferrer L
J Small Anim Pract; 2007 Apr; 48(4):229-32. PubMed ID: 17381769
[TBL] [Abstract][Full Text] [Related]
35. [Infliximab for the management of pyoderma gangrenosum in inflammatory bowel disease: one for all?].
Tanczos BT; Baumgart DC
Z Gastroenterol; 2006 Jul; 44(7):609-10. PubMed ID: 16823703
[No Abstract] [Full Text] [Related]
36. [Sweet's syndrome. Its association with chronic inflammatory bowel disease].
Calvo Catalá J; González Pérez JA; Febrer Bosch I; Oliver Mas V; Herrera Ballester A
An Med Interna; 1990 Jul; 7(7):364-6. PubMed ID: 2103250
[TBL] [Abstract][Full Text] [Related]
37. Bullous pyoderma gangrenosum: a case report and review of the published work.
Sakiyama M; Kobayashi T; Nagata Y; Fujimoto N; Satoh T; Tajima S
J Dermatol; 2012 Dec; 39(12):1010-5. PubMed ID: 22974277
[TBL] [Abstract][Full Text] [Related]
38. Regression of Sweet's syndrome associated with Crohn's disease after anti-Tumour Necrosis Factor therapy.
Rahier JF; Lion L; Dewit O; Lambert M
Acta Gastroenterol Belg; 2005; 68(3):376-9. PubMed ID: 16268426
[TBL] [Abstract][Full Text] [Related]
39. Clinical manifestations of pyoderma gangrenosum associated with inflammatory bowel disease.
Menachem Y; Gotsman I
Isr Med Assoc J; 2004 Feb; 6(2):88-90. PubMed ID: 14986464
[TBL] [Abstract][Full Text] [Related]
40. [Two neutrophilic dermatoses and one multiple myeloma : A case report].
Wolfsperger F; Müller A; Kofler L; Yazdi A
Hautarzt; 2019 Jul; 70(7):527-529. PubMed ID: 30937480
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
